International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

it has agreed to sell its entire equity investment in The Charles Schwab Corporation ("Schwab") (NYSE: SCHW). TD currently holds 184,678,738 shares of Schwab's common stock representing 10.1% ...

OLDSMAR, Fla., January 29, 2025--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) ("Cryo-Cell"), the world’s first private cord blood bank to separate and store stem cells in 1992, ...

Stem cell research always courts controversy and an application by the International Stem Cell Corporation (ISCC) for two UK patents for the creation of synthetic cornea from retinal stem cells ...

Enter the International Stem Cell Corporation ("ISCC") v Comptroller General of Patents case. ISCC applied for two UK patents for stem cell research concerning the creation of synthetic cornea ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

At close: 3 February at 3:00:00 pm GMT-5 ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

1 Day ISCO -2.33% DJIA 0.78% Russell 2K 0.40% Health Care/Life Sciences 1527.38% ...